Jane Street
TERN

Jane Street’s Terns Pharmaceuticals TERN Stock Holding History

Jane Street’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.16M Buy
135,800
+52,800
+64% +$2.17M ﹤0.01% 2983
2025
Q4 		$3.35M Buy
83,000
+68,700
+480% +$1.59M ﹤0.01% 3867
2025
Q3 		$107K Buy
+14,300
New +$91.3K ﹤0.01% 10107
2024
Q4 		– Sell
-31,500
Closed -$263K – 10569
2024
Q3 		$263K Buy
+31,500
New +$259K ﹤0.01% 8244

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Jane Street's TERN Position: Q1 2026 in Review

Jane Street reduced its Terns Pharmaceuticals (TERN) stake by 92% in Q1 2026, selling an estimated $3.35M and leaving 7,231 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #8664.

Jane Street first reported a position in TERN in Q2 2021 and has held it in 13 quarters since. The position peaked at $3.59M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Jane Street held 7,231 shares of Terns Pharmaceuticals worth $381K as of Q1 2026.
  • Jane Street sold 81,606 Terns Pharmaceuticals shares in Q1 2026, an estimated $3.35M.
  • Terns Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8664 holding.
  • Jane Street first reported a position in Terns Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
  • Jane Street's Terns Pharmaceuticals position peaked at $3.59M in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.